Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/association-between-market-competition-and-prices-of-generic-topical-89JSLFj0Dg
References (14)
-
Chintan Dave, A. Kesselheim, E. Fox, P. Qiu, A. Hartzema (2017)
High Generic Drug Prices and Market CompetitionAnnals of Internal Medicine, 167
-
M. Bhatt, B. Bhatt, J. Dorrian, B. McLellan (2019)
Increased topical generic prices by manufacturersJournal of the American Academy of Dermatology, 80
-
Hannah Song, A. Adamson, A. Mostaghimi (2018)
Trends in Medicare spending on topical immunomodulators and chemotherapiesJournal of the American Academy of Dermatology, 78
-
Fiona Morton, Fiona Morton (1999)
Entry decisions in the generic pharmaceutical industry.The Rand journal of economics, 30 3
-
Dave (2017)
High generic drug prices and market competition: a retrospective cohort study.Ann Intern Med, 167
-
Chintan Dave, A. Hartzema, A. Kesselheim (2017)
Prices of Generic Drugs Associated with Numbers of Manufacturers.The New England journal of medicine, 377 26
-
Hannah Song, A. Adamson, A. Mostaghimi (2017)
Medicare Part D Payments for Topical Steroids: Rising Costs and Potential SavingsJAMA Dermatology, 153
-
M. Rosenberg, S. Rosenberg (2016)
Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015.JAMA dermatology, 152 2
-
Bhatt
Increased topical generic prices by manufacturers: an isolated trend or worrisome future?J Am Acad Dermatol
-
A. Kesselheim, J. Avorn, A. Sarpatwari (2016)
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.JAMA, 316 8
-
H. Lim, S. Collins, J. Resneck, J. Bolognia, J. Hodge, T. Rohrer, M. Beek, D. Margolis, A. Sober, M. Weinstock, D. Nerenz, Wendy Begolka, J. Moyano (2017)
The burden of skin disease in the United StatesJournal of the American Academy of Dermatology, 76
-
J. Barbieri, D. Margolis, B. Brod (2017)
Influence of Market Competition on Tetracycline Pricing and Impact of Price Increases on Clinician Prescribing Behavior.The Journal of investigative dermatology, 137 12
-
Jonathan Alpern, Lei Zhang, W. Stauffer, A. Kesselheim (2017)
Trends in Pricing and Generic Competition Within the Oral Antibiotic Drug Market in the United StatesClinical Infectious Diseases, 65
-
H. Powell, A. Adamson (2018)
Medicare Part D payments for brand and generic drugs prescribed by dermatologistsJournal of the American Academy of Dermatology, 79
- Publisher
- American Medical Association
- Copyright
- Copyright 2018 American Medical Association. All Rights Reserved.
- ISSN
- 2168-6068
- eISSN
- 2168-6084
- DOI
- 10.1001/jamadermatol.2018.3798
- Publisher site
- See Article on Publisher Site
Abstract
Key PointsQuestionDoes an association exist between drug price and market competition among the topical dermatologic generic medications most commonly prescribed by dermatologists in the United States? FindingsIn this cost analysis of 116 topical dermatologic generic drugs (70.5% of Medicare Part D dermatologist-coded claims), there was an inverse correlation between drug price and number of manufacturers. Drugs with 1 to 2 manufacturers sustained a 33.2% higher median percentage increase in price than drugs with more than 6 manufacturers. MeaningPolicies that increase market competition among topical dermatologic generic drugs with a limited number of manufacturers may lead to long-term price reductions.
Journal
JAMA Dermatology – American Medical Association
Published: Dec 31, 2018